Two Sigma Securities’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-11,400
Closed -$408K 3128
2023
Q2
$408K Sell
11,400
-13,000
-53% -$373K 0.01% 1596
2023
Q1
$572K Buy
+24,400
New +$697K 0.01% 1168
2022
Q3
Sell
-13,900
Closed -$561K 2774
2022
Q2
$561K Buy
13,900
+10,200
+276% +$505K 0.02% 830
2022
Q1
$245K Buy
+3,700
New +$253K 0.01% 1573
2020
Q1
Sell
-7,100
Closed -$555K 1703
2019
Q4
$555K Buy
+7,100
New +$512K ﹤0.01% 1387

Other funds holding GH

Two Sigma Securities's GH Position: Q4 2024 in Review

Two Sigma Securities sold out of Guardant Health (GH) in Q4 2024, closing a stake of 22,269 shares — an estimated $511K sold.

Two Sigma Securities first reported a position in GH in Q1 2021 and held it in 8 quarters. The position peaked at $701K in Q2 2024. 298 funds tracked by Wall St. Rank hold GH as of Q4 2024.

  • Two Sigma Securities reported no remaining Guardant Health position as of Q4 2024 after selling out during the quarter.
  • Two Sigma Securities sold 22,269 Guardant Health shares in Q4 2024, an estimated $511K.
  • Two Sigma Securities first reported a position in Guardant Health in Q1 2021 and held it in 8 quarters.
  • Two Sigma Securities's Guardant Health position peaked at $701K in Q2 2024.
  • 298 funds tracked by Wall St. Rank held Guardant Health as of Q4 2024.

Based on Two Sigma Securities's 13F filing for Q4 2024, filed 14 Feb 2025.